Health
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test – HospiMedica
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patient’s relative level of antibodies in response to…
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patients relative level of antibodies in response to a previous SARS-CoV-2 infection. The assays new capabilities enable clinicians to establish a baseline to evaluate an individuals immune response to the SARS-CoV-2 virus based on a numerical value and assess relative changes of an individuals immune response to the virus over time. The assay may also help researchers as they begin to understand…
-
Noosa News24 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General21 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General23 hours agoVulnerable youth non-for-profit Allambi Care agrees to end ‘unacceptable’ housing scheme
-
Noosa News20 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan